According to Market IntelliX Research, the global market for Keratolytic Agents should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Keratolytic Agents market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Keratolytic Agents market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Salicylic Acid segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Psoriasis has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Keratolytic Agents include Pfizer Inc, GSK plc, Novartis AG, Mylan NV, Boehringer Ingelheim International GmbH, AstraZeneca, Johnson & Johnson Private Limited, Bayer AG and Merck & Co., Inc, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Keratolytic agents are the type of compounds which break down the outer layer of skin and minimize the thickness of skin damage cells with the help of exfoliation. These agents are applied to soften the skin and is useful in treating several dry skin conditions.
This report aims to provide a comprehensive study of the global market for Keratolytic Agents. Report Highlights:
(1) Global Keratolytic Agents market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Keratolytic Agents market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Keratolytic Agents market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Keratolytic Agents segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Keratolytic Agents segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Keratolytic Agents, capacity, production and trends.
(7) Keratolytic Agents industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Salicylic Acid
Alpha Hydroxy Acid
Azelaic Acid
Tretinoin
Other
Market segment by application, can be divided into
Psoriasis
Acne
Other
Market segment by players, this report covers
Pfizer Inc
GSK plc
Novartis AG
Mylan NV
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private Limited
Bayer AG
Merck & Co., Inc
Bristol-Myers Squibb Company
Cadila Pharmaceuticals
Lilly
LEO Pharma A/S
Cipla Inc
Aurobindo Pharma
Lupin
Sumitomo Corporation
Taro Pharmaceutical Industries Ltd
1 Market Overview
1.1 Keratolytic Agents Definition
1.2 Global Keratolytic Agents Market Size and Forecast
1.2.1 By Revenue, Global Keratolytic Agents Market Size, 2019-2030
1.2.2 By Sales Volume, Global Keratolytic Agents Market Size, 2019-2030
1.2.3 Global Keratolytic Agents Price Trend, 2019-2030
1.3 China Keratolytic Agents Market Size and Forecast
1.3.1 By Revenue, China Keratolytic Agents Market Size, 2019-2030
1.3.2 By Sales Volume, China Keratolytic Agents Market Size, 2019-2030
1.3.3 China Keratolytic Agents Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Keratolytic Agents Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Keratolytic Agents Share in Global Market, 2019-2030
1.4.3 Keratolytic Agents Market Size: China VS Global, 2019-2030
1.5 Keratolytic Agents Market Dynamics
1.5.1 Keratolytic Agents Market Drivers
1.5.2 Keratolytic Agents Market Restraints
1.5.3 Keratolytic Agents Industry Trends
1.5.4 Keratolytic Agents Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Keratolytic Agents Revenue by Company, 2019-2024
2.2 Global Keratolytic Agents Sales Volume by Company, 2019-2024
2.3 Global Keratolytic Agents Price by Company, 2019-2024
2.4 Global Keratolytic Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Keratolytic Agents Concentration Ratio
2.6 Global Keratolytic Agents Mergers & Acquisitions, Expansion Plans
2.7 Global Keratolytic Agents Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Keratolytic Agents Revenue by Company, 2019-2024
3.2 China Keratolytic Agents Sales Volume by Company, 2019-2024
3.3 China Keratolytic Agents Keratolytic Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Keratolytic Agents Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Keratolytic Agents Domestic VS Export
3.6 China Market, Keratolytic Agents Import & Export
3.6.1 China Market, Keratolytic Agents Import & Export, 2019-2030
3.6.2 China Keratolytic Agents Import & Export Trends
3.6.3 Main Sources of China Keratolytic Agents Import
3.6.4 Export Destination of China Keratolytic Agents
4 Keratolytic Agents Production by Region
4.1 Global Keratolytic Agents Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Keratolytic Agents Manufacturers
4.3 Global Major Manufacturers, Keratolytic Agents Capacity Expansion and Future Plans
4.4 Global Keratolytic Agents Capacity by Region
4.5 Global Keratolytic Agents Production by Region
4.5.1 Global Keratolytic Agents Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Keratolytic Agents Production by Region, 2019-2024
4.5.3 Global Keratolytic Agents Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Keratolytic Agents Industry Chain
5.2 Keratolytic Agents Upstream Analysis
5.2.1 Keratolytic Agents Core Raw Materials
5.2.2 Main Manufacturers of Keratolytic Agents Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Keratolytic Agents Production Mode
5.6 Keratolytic Agents Procurement Model
5.7 Keratolytic Agents Industry Sales Model and Sales Channels
5.7.1 Keratolytic Agents Sales Model
5.7.2 Keratolytic Agents Typical Distributors
6 Sights by Type
6.1 Keratolytic Agents Classification
6.1.1 Salicylic Acid
6.1.2 Alpha Hydroxy Acid
6.1.3 Azelaic Acid
6.1.4 Tretinoin
6.1.5 Other
6.2 By Type, Global Keratolytic Agents Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Keratolytic Agents Revenue, 2019-2030
6.4 By Type, Global Keratolytic Agents Sales Volume, 2019-2030
6.5 By Type, Global Keratolytic Agents Price, 2019-2030
7 Sights by Application
7.1 Keratolytic Agents Segment by Application
7.1.1 Psoriasis
7.1.2 Acne
7.1.3 Other
7.2 By Application, Global Keratolytic Agents Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Keratolytic Agents Revenue, 2019-2030
7.4 By Application, Global Keratolytic Agents Sales Volume, 2019-2030
7.5 By Application, Global Keratolytic Agents Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Keratolytic Agents Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Keratolytic Agents Revenue, 2019-2030
8.3 By Region, Global Keratolytic Agents Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Keratolytic Agents Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Keratolytic Agents Market Size Market Share
8.5 Europe
8.5.1 Europe Keratolytic Agents Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Keratolytic Agents Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Keratolytic Agents Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Keratolytic Agents Market Size Market Share
8.7 South America
8.7.1 South America Keratolytic Agents Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Keratolytic Agents Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Keratolytic Agents Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global Keratolytic Agents Revenue, 2019-2030
9.3 By Country, Global Keratolytic Agents Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Keratolytic Agents Market Size, 2019-2030
9.4.2 By Company, U.S. Keratolytic Agents Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Keratolytic Agents Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Keratolytic Agents Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Keratolytic Agents Market Size, 2019-2030
9.5.2 By Company, Europe Keratolytic Agents Sales Volume Market Share, 2023
9.5.3 By Type, Europe Keratolytic Agents Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Keratolytic Agents Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Keratolytic Agents Market Size, 2019-2030
9.6.2 By Company, China Keratolytic Agents Sales Volume Market Share, 2023
9.6.3 By Type, China Keratolytic Agents Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Keratolytic Agents Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Keratolytic Agents Market Size, 2019-2030
9.7.2 By Company, Japan Keratolytic Agents Sales Volume Market Share, 2023
9.7.3 By Type, Japan Keratolytic Agents Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Keratolytic Agents Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Keratolytic Agents Market Size, 2019-2030
9.8.2 By Company, South Korea Keratolytic Agents Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Keratolytic Agents Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Keratolytic Agents Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Keratolytic Agents Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Keratolytic Agents Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Keratolytic Agents Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Keratolytic Agents Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Keratolytic Agents Market Size, 2019-2030
9.10.2 By Company, India Keratolytic Agents Sales Volume Market Share, 2023
9.10.3 By Type, India Keratolytic Agents Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Keratolytic Agents Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Keratolytic Agents Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Keratolytic Agents Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Keratolytic Agents Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Keratolytic Agents Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Inc Keratolytic Agents Models, Specifications and Application
10.1.3 Pfizer Inc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Pfizer Inc Company Profile and Main Business
10.1.5 Pfizer Inc Recent Developments
10.2 GSK plc
10.2.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.2.2 GSK plc Keratolytic Agents Models, Specifications and Application
10.2.3 GSK plc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 GSK plc Company Profile and Main Business
10.2.5 GSK plc Recent Developments
10.3 Novartis AG
10.3.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.3.2 Novartis AG Keratolytic Agents Models, Specifications and Application
10.3.3 Novartis AG Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Novartis AG Company Profile and Main Business
10.3.5 Novartis AG Recent Developments
10.4 Mylan NV
10.4.1 Mylan NV Company Information, Head Office, Market Area and Industry Position
10.4.2 Mylan NV Keratolytic Agents Models, Specifications and Application
10.4.3 Mylan NV Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Mylan NV Company Profile and Main Business
10.4.5 Mylan NV Recent Developments
10.5 Boehringer Ingelheim International GmbH
10.5.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.5.2 Boehringer Ingelheim International GmbH Keratolytic Agents Models, Specifications and Application
10.5.3 Boehringer Ingelheim International GmbH Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.5.5 Boehringer Ingelheim International GmbH Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.6.2 AstraZeneca Keratolytic Agents Models, Specifications and Application
10.6.3 AstraZeneca Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 AstraZeneca Company Profile and Main Business
10.6.5 AstraZeneca Recent Developments
10.7 Johnson & Johnson Private Limited
10.7.1 Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position
10.7.2 Johnson & Johnson Private Limited Keratolytic Agents Models, Specifications and Application
10.7.3 Johnson & Johnson Private Limited Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Johnson & Johnson Private Limited Company Profile and Main Business
10.7.5 Johnson & Johnson Private Limited Recent Developments
10.8 Bayer AG
10.8.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.8.2 Bayer AG Keratolytic Agents Models, Specifications and Application
10.8.3 Bayer AG Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Bayer AG Company Profile and Main Business
10.8.5 Bayer AG Recent Developments
10.9 Merck & Co., Inc
10.9.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.9.2 Merck & Co., Inc Keratolytic Agents Models, Specifications and Application
10.9.3 Merck & Co., Inc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Merck & Co., Inc Company Profile and Main Business
10.9.5 Merck & Co., Inc Recent Developments
10.10 Bristol-Myers Squibb Company
10.10.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.10.2 Bristol-Myers Squibb Company Keratolytic Agents Models, Specifications and Application
10.10.3 Bristol-Myers Squibb Company Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.10.5 Bristol-Myers Squibb Company Recent Developments
10.11 Cadila Pharmaceuticals
10.11.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.11.2 Cadila Pharmaceuticals Keratolytic Agents Models, Specifications and Application
10.11.3 Cadila Pharmaceuticals Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Cadila Pharmaceuticals Company Profile and Main Business
10.11.5 Cadila Pharmaceuticals Recent Developments
10.12 Lilly
10.12.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.12.2 Lilly Keratolytic Agents Models, Specifications and Application
10.12.3 Lilly Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Lilly Company Profile and Main Business
10.12.5 Lilly Recent Developments
10.13 LEO Pharma A/S
10.13.1 LEO Pharma A/S Company Information, Head Office, Market Area and Industry Position
10.13.2 LEO Pharma A/S Keratolytic Agents Models, Specifications and Application
10.13.3 LEO Pharma A/S Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 LEO Pharma A/S Company Profile and Main Business
10.13.5 LEO Pharma A/S Recent Developments
10.14 Cipla Inc
10.14.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Cipla Inc Keratolytic Agents Models, Specifications and Application
10.14.3 Cipla Inc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Cipla Inc Company Profile and Main Business
10.14.5 Cipla Inc Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.15.2 Aurobindo Pharma Keratolytic Agents Models, Specifications and Application
10.15.3 Aurobindo Pharma Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Aurobindo Pharma Company Profile and Main Business
10.15.5 Aurobindo Pharma Recent Developments
10.16 Lupin
10.16.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.16.2 Lupin Keratolytic Agents Models, Specifications and Application
10.16.3 Lupin Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Lupin Company Profile and Main Business
10.16.5 Lupin Recent Developments
10.17 Sumitomo Corporation
10.17.1 Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position
10.17.2 Sumitomo Corporation Keratolytic Agents Models, Specifications and Application
10.17.3 Sumitomo Corporation Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Sumitomo Corporation Company Profile and Main Business
10.17.5 Sumitomo Corporation Recent Developments
10.18 Taro Pharmaceutical Industries Ltd
10.18.1 Taro Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.18.2 Taro Pharmaceutical Industries Ltd Keratolytic Agents Models, Specifications and Application
10.18.3 Taro Pharmaceutical Industries Ltd Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.18.4 Taro Pharmaceutical Industries Ltd Company Profile and Main Business
10.18.5 Taro Pharmaceutical Industries Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Keratolytic Agents Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Keratolytic Agents Market Restraints
Table 3. Keratolytic Agents Market Trends
Table 4. Keratolytic Agents Industry Policy
Table 5. Global Keratolytic Agents Revenue by Company, 2019-2024, US$ million
Table 6. Global Keratolytic Agents Revenue Market Share by Company, 2019-2024
Table 7. Global Keratolytic Agents Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Keratolytic Agents Sales Volume Market Share by Company, 2019-2024
Table 9. Global Keratolytic Agents Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Keratolytic Agents Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Keratolytic Agents Mergers & Acquisitions, Expansion Plans
Table 12. Global Keratolytic Agents Manufacturers Product Type
Table 13. China Keratolytic Agents Revenue by Company, 2019-2024, US$ million
Table 14. China Keratolytic Agents Revenue Market Share by Company, 2019-2024
Table 15. China Keratolytic Agents Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Keratolytic Agents Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Keratolytic Agents Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Keratolytic Agents Import & Export Trends
Table 19. Main Sources of China Keratolytic Agents Import
Table 20. Export Destination of China Keratolytic Agents
Table 21. Global Headquarters and Manufacturing Base of Keratolytic Agents Manufacturers
Table 22. Global Major Manufacturers, Keratolytic Agents Capacity Expansion and Future Plans
Table 23. Global Keratolytic Agents Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Keratolytic Agents Production by Region, 2019-2024, (K Units)
Table 25. Global Keratolytic Agents Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Keratolytic Agents Upstream (Raw Materials)
Table 27. Global Keratolytic Agents Typical Customers
Table 28. Keratolytic Agents Typical Distributors
Table 29. By Type, Global Keratolytic Agents Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Keratolytic Agents Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Keratolytic Agents Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Keratolytic Agents Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Keratolytic Agents Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Keratolytic Agents Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Keratolytic Agents Revenue Market Share, 2019-2030
Table 37. By Country, Global Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Keratolytic Agents Sales Volume Market Share, 2019-2030
Table 39. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Inc Keratolytic Agents Models, Specifications and Application
Table 41. Pfizer Inc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Pfizer Inc Company Profile and Main Business
Table 43. Pfizer Inc Recent Developments
Table 44. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 45. GSK plc Keratolytic Agents Models, Specifications and Application
Table 46. GSK plc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. GSK plc Company Profile and Main Business
Table 48. GSK plc Recent Developments
Table 49. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 50. Novartis AG Keratolytic Agents Models, Specifications and Application
Table 51. Novartis AG Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Novartis AG Company Profile and Main Business
Table 53. Novartis AG Recent Developments
Table 54. Mylan NV Company Information, Head Office, Market Area and Industry Position
Table 55. Mylan NV Keratolytic Agents Models, Specifications and Application
Table 56. Mylan NV Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Mylan NV Company Profile and Main Business
Table 58. Mylan NV Recent Developments
Table 59. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 60. Boehringer Ingelheim International GmbH Keratolytic Agents Models, Specifications and Application
Table 61. Boehringer Ingelheim International GmbH Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 63. Boehringer Ingelheim International GmbH Recent Developments
Table 64. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 65. AstraZeneca Keratolytic Agents Models, Specifications and Application
Table 66. AstraZeneca Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. AstraZeneca Company Profile and Main Business
Table 68. AstraZeneca Recent Developments
Table 69. Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position
Table 70. Johnson & Johnson Private Limited Keratolytic Agents Models, Specifications and Application
Table 71. Johnson & Johnson Private Limited Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Johnson & Johnson Private Limited Company Profile and Main Business
Table 73. Johnson & Johnson Private Limited Recent Developments
Table 74. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 75. Bayer AG Keratolytic Agents Models, Specifications and Application
Table 76. Bayer AG Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Bayer AG Company Profile and Main Business
Table 78. Bayer AG Recent Developments
Table 79. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 80. Merck & Co., Inc Keratolytic Agents Models, Specifications and Application
Table 81. Merck & Co., Inc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Merck & Co., Inc Company Profile and Main Business
Table 83. Merck & Co., Inc Recent Developments
Table 84. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 85. Bristol-Myers Squibb Company Keratolytic Agents Models, Specifications and Application
Table 86. Bristol-Myers Squibb Company Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Bristol-Myers Squibb Company Company Profile and Main Business
Table 88. Bristol-Myers Squibb Company Recent Developments
Table 89. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 90. Cadila Pharmaceuticals Keratolytic Agents Models, Specifications and Application
Table 91. Cadila Pharmaceuticals Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Cadila Pharmaceuticals Company Profile and Main Business
Table 93. Cadila Pharmaceuticals Recent Developments
Table 94. Lilly Company Information, Head Office, Market Area and Industry Position
Table 95. Lilly Keratolytic Agents Models, Specifications and Application
Table 96. Lilly Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Lilly Company Profile and Main Business
Table 98. Lilly Recent Developments
Table 99. LEO Pharma A/S Company Information, Head Office, Market Area and Industry Position
Table 100. LEO Pharma A/S Keratolytic Agents Models, Specifications and Application
Table 101. LEO Pharma A/S Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. LEO Pharma A/S Company Profile and Main Business
Table 103. LEO Pharma A/S Recent Developments
Table 104. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Cipla Inc Keratolytic Agents Models, Specifications and Application
Table 106. Cipla Inc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Cipla Inc Company Profile and Main Business
Table 108. Cipla Inc Recent Developments
Table 109. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 110. Aurobindo Pharma Keratolytic Agents Models, Specifications and Application
Table 111. Aurobindo Pharma Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Aurobindo Pharma Company Profile and Main Business
Table 113. Aurobindo Pharma Recent Developments
Table 114. Lupin Company Information, Head Office, Market Area and Industry Position
Table 115. Lupin Keratolytic Agents Models, Specifications and Application
Table 116. Lupin Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 117. Lupin Company Profile and Main Business
Table 118. Lupin Recent Developments
Table 119. Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position
Table 120. Sumitomo Corporation Keratolytic Agents Models, Specifications and Application
Table 121. Sumitomo Corporation Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 122. Sumitomo Corporation Company Profile and Main Business
Table 123. Sumitomo Corporation Recent Developments
Table 124. Taro Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 125. Taro Pharmaceutical Industries Ltd Keratolytic Agents Models, Specifications and Application
Table 126. Taro Pharmaceutical Industries Ltd Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 127. Taro Pharmaceutical Industries Ltd Company Profile and Main Business
Table 128. Taro Pharmaceutical Industries Ltd Recent Developments
List of Figure
Figure 1. Keratolytic Agents Picture
Figure 2. By Revenue, Global Keratolytic Agents Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Keratolytic Agents Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Keratolytic Agents Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Keratolytic Agents Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Keratolytic Agents Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Keratolytic Agents Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Keratolytic Agents Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Keratolytic Agents Share of Global Market, 2019-2030
Figure 10. Global Keratolytic Agents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Keratolytic Agents Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Keratolytic Agents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Keratolytic Agents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Keratolytic Agents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Keratolytic Agents Domestic VS Export, 2022
Figure 16. Global Keratolytic Agents Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Keratolytic Agents Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Keratolytic Agents Production Market Share & Forecast by Region, 2019-2030
Figure 19. Keratolytic Agents Industry Chain
Figure 20. Keratolytic Agents Procurement Model
Figure 21. Keratolytic Agents Sales Model
Figure 22. Keratolytic Agents Sales Channels, Direct Sales and Distribution
Figure 23. Salicylic Acid
Figure 24. Alpha Hydroxy Acid
Figure 25. Azelaic Acid
Figure 26. Tretinoin
Figure 27. Other
Figure 28. By Type, Global Keratolytic Agents Revenue, 2019-2030, US$ Million
Figure 29. By Type, Global Keratolytic Agents Revenue Market Share, 2019-2030
Figure 30. By Type, Global Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 31. By Type, Global Keratolytic Agents Sales Volume Market Share, 2019-2030
Figure 32. By Type, Global Keratolytic Agents Price, 2019-2030, (US$/Unit)
Figure 33. Psoriasis
Figure 34. Acne
Figure 35. Other
Figure 36. By Application, Global Keratolytic Agents Revenue, 2019-2030, US$ Million
Figure 37. By Application, Global Keratolytic Agents Revenue Market Share, 2019-2030
Figure 38. By Application, Global Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 39. By Application, Global Keratolytic Agents Sales Volume Market Share, 2019-2030
Figure 40. By Application, Global Keratolytic Agents Price, 2019-2030, (US$/Unit)
Figure 41. By Region, Global Keratolytic Agents Revenue Market Share, 2019-2030
Figure 42. By Region, Global Keratolytic Agents Sales Volume Market Share, 2019-2030
Figure 43. North America Keratolytic Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, North America Keratolytic Agents Revenue Market Share, 2022
Figure 45. Europe Keratolytic Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, Europe Keratolytic Agents Revenue Market Share, 2022
Figure 47. Asia Pacific Keratolytic Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country/Region, Asia Pacific Keratolytic Agents Revenue Market Share, 2022
Figure 49. South America Keratolytic Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. By Country, South America Keratolytic Agents Revenue Market Share, 2022
Figure 51. Middle East & Africa Keratolytic Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 52. U.S. Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 53. By Company, U.S. Keratolytic Agents Market Share, 2022
Figure 54. By Type, U.S. Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 57. By Company, Europe Keratolytic Agents Market Share, 2022
Figure 58. By Type, Europe Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 60. China Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 61. By Company, China Keratolytic Agents Market Share, 2022
Figure 62. By Type, China Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 65. By Company, Japan Keratolytic Agents Market Share, 2022
Figure 66. By Type, Japan Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 69. By Company, South Korea Keratolytic Agents Market Share, 2022
Figure 70. By Type, South Korea Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 73. By Company, Southeast Asia Keratolytic Agents Market Share, 2022
Figure 74. By Type, Southeast Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 76. India Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 77. By Company, India Keratolytic Agents Market Share, 2022
Figure 78. By Type, India Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Keratolytic Agents Sales Volume, 2019-2030, (K Units)
Figure 81. By Company, Middle East & Asia Keratolytic Agents Market Share, 2022
Figure 82. By Type, Middle East & Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|